Related Experiment Video
Updated: Jul 19, 2026
07:54
Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
Published on: December 21, 2019
The pathogenesis of mesothelioma
Michele Carbone1, Carlos W M Bedrossian
1Thoracic Oncology Program, Cancer Research Center of Hawaii, University of Hawaii, Honolulu, Hawaii 96813, USA. mcarbone@crch.hawaii.edu
Seminars in Diagnostic Pathology
|October 19, 2006
Summary
Asbestos exposure increases malignant mesothelioma (MM) risk. New research links MM to AP-1 pathway activation, TNF-alpha signaling, and genetic susceptibility, explaining why only some exposed individuals develop this cancer.
Area of Science:
- Oncology
- Environmental Health
- Pathogenesis
Background:
- Widespread asbestos exposure historically correlates with increased malignant mesothelioma (MM) incidence.
- The precise mechanisms of asbestos-induced carcinogenesis remained largely unknown until recent discoveries.
Purpose of the Study:
- To elucidate the molecular mechanisms underlying asbestos-related malignant mesothelioma.
- To investigate the roles of specific cellular pathways, genetic factors, and co-exposures in MM development.
Main Methods:
- Analysis of AP-1 pathway activation and TNF-alpha signaling in response to asbestos exposure.
- Investigation of genetic susceptibility in families with high MM incidence.
- Examination of the cocarcinogenic effects of SV40 and asbestos.
Main Results:
- Asbestos exposure activates the AP-1 pathway and TNF-alpha signaling, promoting cell survival and division.
- Genetic factors and co-exposure to agents like SV40 significantly influence MM risk.
- Lung macrophages contribute to carcinogenesis via mutagenic oxygen radicals.
Conclusions:
- MM pathogenesis involves complex interactions between asbestos fibers, cellular signaling pathways (AP-1, TNF-alpha/NF-kappaB), and host factors.
- Genetic predisposition and co-exposures (e.g., SV40) can lower the threshold for developing MM.
- Understanding these mechanisms offers new avenues for MM prevention and therapeutic strategies.
Related Concept Videos
01:30Pleural Disorders: Types and Brief Description
The pleura is a vital part of the respiratory system. It's a double-layered membrane surrounding the lungs and lining the chest cavity. The two layers of the pleura are:
02:30Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
01:20Asthma: Pathogenesis and Management
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
01:28Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
01:23Cystic Fibrosis: Pathogenesis
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...